scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0306-4522(00)00065-8 |
P698 | PubMed publication ID | 10842013 |
P2093 | author name string | Davies HA | |
Stewart MG | |||
Cambon K | |||
P2860 | cites work | Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease | Q24308731 |
Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study | Q24319783 | ||
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families | Q27860677 | ||
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease | Q28238269 | ||
Apolipoprotein E: cholesterol transport protein with expanding role in cell biology | Q28294791 | ||
Selective alterations in the cellular distribution of apolipoprotein E immunoreactivity following transient cerebral ischaemia in the rat | Q28569838 | ||
Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth | Q28771743 | ||
Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment | Q29547294 | ||
Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense-core vesicles. | Q30991642 | ||
Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease. | Q32091544 | ||
Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females | Q33563135 | ||
SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele | Q33735332 | ||
Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line | Q33848287 | ||
Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? | Q34390023 | ||
Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele. | Q53213466 | ||
Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. | Q53321766 | ||
The unbiased estimation of number and sizes of arbitrary particles using the disector | Q71397942 | ||
Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease | Q72119373 | ||
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease | Q34662682 | ||
Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease | Q36604545 | ||
Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice. | Q36840098 | ||
Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells | Q37011453 | ||
Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease | Q40397850 | ||
The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization | Q41308477 | ||
Differential neurotrophic effects of apolipoprotein E in aged transgenic mice | Q41664893 | ||
Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration. | Q41671941 | ||
Synaptic loss in Alzheimer's disease and other dementias | Q41984306 | ||
Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele | Q42528671 | ||
Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease | Q43958274 | ||
Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro | Q45081026 | ||
Cells of origin of entorhinal cortical afferents to the hippocampus and fascia dentata of the rat | Q45127850 | ||
Increased apolipoprotein E mRNA in the hippocampus in Alzheimer disease and in rats after entorhinal cortex lesioning | Q46163083 | ||
Neurodegeneration in the central nervous system of apoE-deficient mice | Q46455236 | ||
Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: implications for Alzheimer's disease. | Q46833795 | ||
Synaptic and neuritic alterations during the progression of Alzheimer's disease | Q46842058 | ||
Alzheimer's disease and aging: effects on perforant pathway perikarya and synapses | Q46942956 | ||
Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E epsilon4 allele | Q47298772 | ||
Regionally specific neuronal expression of human APOE gene in transgenic mice | Q47972600 | ||
Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse | Q48024701 | ||
Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls | Q48092219 | ||
Plasticity of the synaptic contact zone following loss of synapses in the cerebral cortex of aging humans | Q48192893 | ||
Apolipoprotein E deficiency worsens outcome from global cerebral ischemia in the mouse | Q48220117 | ||
Increased neuronal damage in apolipoprotein E-deficient mice following global ischaemia | Q48234274 | ||
Hippocampal neuron and synaptophysin-positive bouton number in aging C57BL/6 mice | Q48245845 | ||
Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats | Q48256982 | ||
Sialylated human apolipoprotein E (apoEs) is preferentially associated with neuron-enriched cultures from APOE transgenic mice | Q48263418 | ||
Perforant pathway changes and the memory impairment of Alzheimer's disease | Q48290487 | ||
Synapse loss in the temporal lobe in Alzheimer's disease | Q48338615 | ||
Synapses in hippocampus occupy only 1-2% of cell membranes and are spaced less than half-micron apart: a quantitative ultrastructural analysis with discussion of physiological implications | Q48411428 | ||
Age‐related loss of axospinous synapses formed by two afferent systems in the rat dentate gyrus as revealed by the unbiased stereological dissector technique | Q48429040 | ||
Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. | Q48477194 | ||
Regional synaptic pathology in Alzheimer's disease | Q48482937 | ||
Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice | Q48492024 | ||
Sex differences in the dendritic branching of dentate granule cells following differential experience | Q48495280 | ||
Alteration in the pattern of nerve terminal protein immunoreactivity in the perforant pathway in Alzheimer's disease and in rats after entorhinal lesions | Q48519799 | ||
MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease | Q48548576 | ||
Isoform-specific effect of apolipoprotein E on cell survival and beta-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures. | Q48558846 | ||
Alzheimer's disease: in vivo detection of differential vulnerability of brain regions | Q48589523 | ||
Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. | Q48650804 | ||
Apolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischemia | Q48664618 | ||
Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning | Q48668350 | ||
Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease | Q48795523 | ||
Human APOE protein localized in brains of transgenic mice. | Q48859995 | ||
Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity | Q48983820 | ||
Early effect of ApoE-epsilon 4 allele on cognitive results in a group of highly performing subjects: the EVA study. Etude sur le Vieillissement Artériel. | Q52006815 | ||
Apolipoprotein E, memory and Alzheimer's disease. | Q52047830 | ||
Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. | Q52052697 | ||
Alzheimer pathology of patients carrying apolipoprotein E epsilon 4 allele. | Q53210396 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 685-692 | |
P577 | publication date | 2000-01-01 | |
P1433 | published in | Neuroscience | Q15708571 |
P1476 | title | Synaptic loss is accompanied by an increase in synaptic area in the dentate gyrus of aged human apolipoprotein E4 transgenic mice | |
P478 | volume | 97 |
Q91799187 | (-)-Phenserine and the prevention of pre-programmed cell death and neuroinflammation in mild traumatic brain injury and Alzheimer's disease challenged mice |
Q58611582 | APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease |
Q34512261 | Altered PET functional brain responses in cognitively intact elderly persons at risk for Alzheimer disease (carriers of the epsilon4 allele) |
Q44188025 | Animal model of dementia induced by entorhinal synaptic damage and partial restoration of cognitive deficits by BDNF and carnitine |
Q42233162 | ApoE isoforms differentially regulates cleavage and secretion of BDNF. |
Q30341746 | ApoE-dependent plasticity in Alzheimer's disease. |
Q30539979 | ApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice |
Q37009967 | Apolipoprotein E and cholesterol in aging and disease in the brain |
Q34628212 | Apolipoprotein E in synaptic plasticity and Alzheimer's disease: potential cellular and molecular mechanisms |
Q35794564 | Apolipoprotein E is a prime suspect, not just an accomplice, in Alzheimer's disease. |
Q44591025 | Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer's disease |
Q34497951 | Apolipoprotein E: From lipid transport to neurobiology |
Q36307402 | Association of lifelong exposure to cognitive reserve-enhancing factors with dementia risk: A community-based cohort study. |
Q45961668 | Correlation between genetic polymorphisms and stroke recovery: analysis of the GAIN Americas and GAIN International Studies. |
Q37731946 | Diet and age interactions with regards to cholesterol regulation and brain pathogenesis |
Q44182865 | Differential effect of corticosterone on spatial learning abilities in apolipoprotein E knockout and C57BL/6J mice |
Q33919169 | Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E. |
Q49144756 | Increased neuronal damage and apoE immunoreactivity in human apolipoprotein E, E4 isoform-specific, transgenic mice after global cerebral ischaemia |
Q52014758 | Maintained synaptophysin immunoreactivity in Tg2576 transgenic mice during aging: correlations with cognitive impairment. |
Q52018805 | Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E. |
Q44756782 | Morphometry of age pigment (lipofuscin) and of ceroid pigment deposits associated with vitamin E deficiency |
Q37633047 | Neuronal nicotinic acetylcholine receptor-cholesterol crosstalk in Alzheimer's disease. |
Q34976296 | Neuroplasticity in Alzheimer's disease |
Q49045928 | No association between apolipoprotein E polymorphisms and general cognitive ability in children |
Q35864607 | Progress toward identification of protease activity involved in proteolysis of apolipoprotein e in human brain |
Q35677207 | Reduced hippocampal CA2, CA3, and dentate gyrus activity in asymptomatic people at genetic risk for Alzheimer's disease. |
Q37002807 | Selective effect of Apo e4 on CA3 and dentate in normal aging and Alzheimer's disease using high resolution MRI at 4 T. |
Q33575225 | Selective effect of age, Apo e4, and Alzheimer's disease on hippocampal subfields |
Q42513397 | Stress alleviates reduced expression of cell adhesion molecules (NCAM, L1), and deficits in learning and corticosterone regulation of apolipoprotein E knockout mice |
Q42342648 | Synapses in neurodegenerative diseases |
Q34603092 | The role of apolipoprotein E in Alzheimer's disease |